🔎 Trials Near Me

Beranda › Kanker Kepala dan Leher › New York › New York City

Uji klinis Kanker Kepala dan Leher di New York City, NY

21 studi untuk Kanker Kepala dan Leher mencari peserta di lokasi sekitar New York City (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Menerima pesertaFase 1/2
  • Columbia University Medical Center, New York
  • Memorial Sloan Kettering, New York
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT04585750

FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC

Menerima pesertaFase 2/3
  • Site #0155, New York
  • Site#0142, New York
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06788990

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

Menerima pesertaFase 2
  • Memorial Sloan Kettering Hospital, New York
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06172478

A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors

Menerima pesertaFase 1
  • Icahn School of Medicine at Mt. Sinai, New York
  • Memorial Sloan Kettering Cancer Center, New York
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT07020117

First in Human Study of TUB-030 in Patients With Advanced Solid Tumors

Menerima pesertaFase 1/2
  • Mount Sinai, New York
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 11 Sep 2026 · NCT06657222

A Study of Decreasing Radiation Therapy and Chemotherapy in People With Head and Neck Cancer

Menerima pesertaFase 2
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 12 Agu 2026 · NCT05544136

Reflectance Confocal Microscopy of Oral Cancers in Vivo: a Preliminary Trial Comparing Intra-oral Imaging With Pathology

Menerima pesertaStudi observasional
  • Memorial Sloan Kettering Cancer Center, New York
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 4 Agu 2026 · NCT02507141

A Study of Cemiplimab With Chemotherapy and Immunotherapy in People With Head and Neck Cancer

Menerima pesertaFase 1
  • Memorial Sloan Kettering Cancer Center, New York
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 21 Jul 2026 · NCT04722523

A Study of a New PET Scanner in People With Cancer

Menerima pesertaStudi observasional
  • Memorial Sloan Kettering Cancer Center, New York
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 8 Jul 2026 · NCT07690917

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

Menerima pesertaFase 1/2
  • Memorial Sloan Kettering Cancer Center, New York
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 7 Jul 2026 · NCT05768139

Implementing the NYU Electronic Patient Visit Assessment (ePVA) for Head and Neck Cancer In Rural and Urban Populations

Menerima peserta
  • NYU Meyers College of Nursing, New York
  • NYU Langone Perlmutter Cancer Center, New York
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 6 Jul 2026 · NCT06030011

A Study of Neurocognitive Tests and Questionnaires for People With Head and Neck Cancer Who Are Undergoing Radiation Therapy

Menerima pesertaStudi observasional
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Usia 18 hingga 89 · Semua jenis kelamin · Diperbarui 5 Jun 2026 · NCT05207098

Brodalumab in the Treatment of Immune-Related Adverse Events

Menerima pesertaFase 1
  • Columbia University Irving Medical Center, New York
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 13 Mei 2026 · NCT06673329

New MRI Biomarkers in Head and Neck Cancers

Menerima pesertaStudi observasional
  • Memorial Sloan Kettering Cancer Center, New York
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Apr 2026 · NCT03483337

Prospective Evaluation of Pencil Beam Scanning Proton Therapy for Previously Irradiated Tumors

Menerima peserta
  • The New York Proton Center, New York
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 13 Apr 2026 · NCT05313191

Impact of Photobiomodulation (PBM) on Biomarkers of Radiation Lymphedema and Fibrosis in Head and Neck Cancer Patients

Menerima peserta
  • NYU Langone Health, New York
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Mar 2026 · NCT06708754

Stereotactic MRI-guided Focused Ultrasound Mesencephalotomy

Menerima peserta
  • Weill Cornell Medicine, New York
Usia 18 hingga 85 · Semua jenis kelamin · Diperbarui 12 Feb 2026 · NCT07405645

VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

Menerima pesertaFase 1/2
  • Weill Cornell Medicine, Cornell University (site 126), New York
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 11 Des 2025 · NCT03556228

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Menerima pesertaStudi observasional
  • Massive Bio SYNERGY-AI site, New York
Semua usia · Semua jenis kelamin · Diperbarui 28 Okt 2025 · NCT03452774

Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors

Menerima pesertaFase 1
  • Memorial Sloan Kettering, New York
  • Columbia University Herbert Irving Comprehensive Cancer Center, New York
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Agu 2025 · NCT04429542

Comprehensive Outcomes for After Cancer Health

Menerima pesertaSukarelawan sehat diterima
  • Memorial Sloan Kettering Cancer Center, New York
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 11 Des 2024 · NCT05349227

Uji klinis Kanker Kepala dan Leher di kota lain

Studi lain di New York City

Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.